Inovio Pharmaceuticals Inc (INO)
4.065
+0.10
(+2.39%)
USD |
NASDAQ |
Nov 21, 16:00
4.065
0.00 (0.00%)
After-Hours: 17:38
Inovio Pharmaceuticals Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.1429 |
| September 30, 2023 | 0.1193 |
| June 30, 2023 | 0.0986 |
| March 31, 2023 | 0.0823 |
| December 31, 2022 | 0.0747 |
| September 30, 2022 | 0.0611 |
| June 30, 2022 | 0.0555 |
| March 31, 2022 | 0.0456 |
| December 31, 2021 | 0.0374 |
| September 30, 2021 | 0.0319 |
| June 30, 2021 | 0.0286 |
| March 31, 2021 | 0.0242 |
| December 31, 2020 | 0.0405 |
| September 30, 2020 | 0.1658 |
| June 30, 2020 | 0.4272 |
| March 31, 2020 | 0.4153 |
| December 31, 2019 | 22.42 |
| September 30, 2019 | 2.080 |
| June 30, 2019 | 1.170 |
| March 31, 2019 | 0.7773 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Mar 2024
22.42
Maximum
Dec 2019
1.278
Average
0.0611
Median
Sep 2022
Debt to Equity Ratio Benchmarks
| Novavax Inc | -0.3215 |
| Baxter International Inc | 1.643 |
| AIM ImmunoTech Inc | 0.9382 |
| Protalix BioTherapeutics Inc | 0.00 |
| Armata Pharmaceuticals Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 107.06M |
| Total Liabilities (Quarterly) | 33.52M |
| Shareholders Equity (Quarterly) | 73.54M |